Keywords: Abbott Labs, Financial results, Fourth-quarter and full-year 2012

Abbott Labs 4th-qtr net income plunges

Article | 23 January 2013

Print This

US health care major Abbott Laboratories (NYSE: ABT) posted sales of $10.84 billion for the fourth quarter of 2012, up4.4% on a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in